At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Low Dose Ketamine (LDK) Versus Morphine for Acute Pain Control in the Emergency Department
In Brief
A Phase 4 clinical trial evaluating Ketamine and Morphine for Abdomen, Acute and 4 related conditions. Completed, enrolled 45 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the safety and effectiveness of intravenous low dose ketamine (LDK) to the industry standard of morphine (MOR) in regards to controlling acute pain in the emergency department. Both LDK and morphine have side effects. The amount and character of these side effects will be compared. Additionally, the degree of sedation or agitation will be specifically measured. The aim of this current study is to make this comparison and shift the evidence for LDK use from the anecdotal to the scientific.
Study Details
Timeline
Interventions
0.3 mg/kg ketamine Intravenous push (IVP) over 5 minutes. Total of two possible doses.
0.1 mg/kg Morphine IVP over 5 minutes. Total of two possible doses.